The Cuban scientific community is currently working on a third Covid-19 vaccine candidate, the first needle-free injection that would be applied through the nasal tract.
Cuba works on its third anti-Covid-19 vaccine candidate
Cuba reports 65 new cases for COVID 19, exceeding 7,000 since March
Cuba studied 8,097 samples for COVID 19, resulting in 65 positive ones. The country accumulates 866, 228 samples carried out and 7, 035 positive ones (0.81%), exceeding 7,000 since March.
Cuba shows important progress in vaccines development against COVID-19
Cuba begins a promising week for its vaccine candidates against COVID-19 with the beginning of Soberana 02's clinical trials Monday and the presentation of the documentation of another possible drug developed by the Center for Genetic Engineering and Biotechnology (CIGB).
Cuba assures encouraging results for its first COVID-19 vaccine candidate
The Finlay Institute of Vaccines (IFV), the leading institution in the development of vaccines in Cuba, assured Monday on Twitter the encouraging preliminary results of the first Cuban vaccine candidate against COVID-19, named Sovereign 01.
Cuban medical brigade assures diagnosis for Covid-19 in Venezuela
Experts from the Cuban medical mission in Venezuela guarantee the processing of PCR samples for the diagnosis of COVID-19, in a modern laboratory of molecular biology.
Cuba reports 35 new cases of COVID-19, 29 medical discharges and one death
Cuba studied for COVID-19, 8,192 samples, resulting in 35 positive ones. The country accumulates 858, 131 samples carried out and 6, 970 positive (0.81%).
At the close of November 1, 3,746 patients are in hospitals for clinical epidemiological surveillance, of which 844 are suspected, 2,381 under surveillance and 521 confirmed.
Cuba reports 35 new cases of COVID 19, 46 discharges and no deaths
Cuba studied 8,245 samples for COVID-19, resulting in 35 positive ones. The country accumulates 832, 287 samples carried out and 6, 801 positive (0.82%).
At the close of October 29, 3,690 patients are in hospitals for clinical epidemiological surveillance, of which 952 are suspects, 2,245 under surveillance and 493 confirmed.
Cuba reports 39 new cases of Covid-19
The Cuban health ministry reported today 39 new positive cases of SARS-CoV-2, coronavirus that causes COVID-19, for a total of 6,766 in the country.
Cuba reports 49 new cases of Covid-19
The Cuban health ministry reported today 49 new positive cases of SARS-CoV-2, coronavirus that causes COVID-19, for a total of 6,727 in the country.
Cuba approves clinical trial for its second vaccine candidate against Covid-19
Cuba's Center for State Control of Medicines, Equipment and Medical Devices (CECMED) certified the clinical trial phase I for the vaccine candidate against Covid-19, Soberana 02, the Finlay Institute reported.
Cuba reports 83 new cases of Covid-19
The Cuban health ministry reported today 83 new positive cases of SARS-CoV-2, coronavirus that causes COVID-19, for a total of 6,678 in the country.
Cuban universal health system seriously damaged by the US blockade
The US economic, commercial and financial blockade has caused much damage to Cuba's universal health care system, with losses in the order of 160,260,880 dollars from April 2019 to March 2020.
Cuba reports 63 new cases of Covid-19
The Cuban health ministry reported today 63 new positive cases of SARS-CoV-2, coronavirus that causes COVID-19, for a total of 6,368 in the country.
Argentine entity awards 2020 Democracy Award to Cuba's Henry Reeve Contingent
Cuba's Henry Reeve International Medical Contingent was honored with the 2020 Democracy Award to the outstanding Latin American personality, awarded by Argentina´s Caras y Caretas Cultural Center.
Cuba announces its second vaccine candidate against COVID-19
A second Cuban vaccine candidate will receive in the coming days the corresponding authorization from the Center for State Control of Drugs, Equipment and Medical Devices (CECMED by its Spanish acronym) for the beginning of its phase 1 clinical evaluation in healthy adults, after which it will be proposed application in the pediatric population.